IASO BioMed, Inc. - FORM 10-K - EX-21.1 - CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - April 16, 2018

Attached files

file filename
EX-3.1 - CERTIFICATE OF INCORPORATION OF IASO BIOMED, INC., FILED MARCH 11, WITH THE SECR - IASO BioMed, Inc.f31.htm
EX-31.2 - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - IASO BioMed, Inc.f312.htm
EX-31.1 - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - IASO BioMed, Inc.f311.htm
EX-14.1 - IASO BIOMED, INC. CODE OF ETHICS FOR SENIOR FINANCIAL MANAGEMENT - IASO BioMed, Inc.f141.htm
EX-10.3 - AMENDMENT NO. 1 TO THE LICENSE AGREEMENT BY AND AMONG IASO BIOMED, INC. AND THE - IASO BioMed, Inc.f103.htm
EX-4.2 - FORM OF SUBSCRIPTION AGREEMENT, PUBLIC OFFERING - IASO BioMed, Inc.f42.htm
EX-3.2 - BYLAWS OF IASO BIOMED, INC - IASO BioMed, Inc.f32.htm
10-K - FORM 10-K - IASO BioMed, Inc.iaso10-k.htm

EXHIBIT 21.1


CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I, Richard Schell, hereby certify that, to the best of my knowledge, the Annual Report on Form 10-K of IASO BioMed, Inc. for the year ended December 31, 2017, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of IASO BioMed, Inc.


 

/s/ Richard M. Schell

 

Richard M. Schell

 

Principal Executive Officer

 

April 16, 2018



I, Duane Knight, hereby certify that, to the best of my knowledge, the Annual Report on Form 10-K of IASO BioMed, Inc. for the year ended December 31, 2017, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of IASO BioMed, Inc.



 

/s/ Duane C. Knight

 

Duane C. Knight

 

Principal Financial Officer

 

April 16, 2018


A signed original of this written statement required by Section 906 has been provided to IASO BioMed, Inc. and will be retained by IASO BioMed, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.




IASO BioMed, Inc. Reports